Chen H - Search Results

1

Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.

Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H. Zhang T, et al. Among authors: chen h, chen y. Mol Cancer. 2021 Aug 17;20(1):102. doi: 10.1186/s12943-021-01391-x. Mol Cancer. 2021. PMID: 34404402 Free PMC article. No abstract available.

2

Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.

Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H. Zhang T, et al. Among authors: chen h, chen y. Mol Cancer. 2020 May 13;19(1):90. doi: 10.1186/s12943-020-01202-9. Mol Cancer. 2020. PMID: 32404161 Free PMC article.

3

Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.

Zhang T, Qu R, Chan S, Lai M, Tong L, Feng F, Chen H, Song T, Song P, Bai G, Liu Y, Wang Y, Li Y, Su Y, Shen Y, Sun Y, Chen Y, Geng M, Ding K, Ding J, Xie H. Zhang T, et al. Among authors: chen h, chen y. Mol Cancer. 2023 Aug 19;22(1):139. doi: 10.1186/s12943-023-01842-7. Mol Cancer. 2023. PMID: 37598189 Free PMC article. No abstract available.

4

Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study.

Shi Y, Li B, Wu L, Pan Y, Pan Z, Liu Y, Fan Y, Ji Y, Fang J, Shi Q, Shi J, Gao H, Hu Y, Wang X, He Z, Ma R, Zhang Y, Jiang D, Bai Y, Zhang Y, Huang L, Zhou T, Liu H, Wang D, Wen Q, Chen G, Zang A, Wang X, Zhang X, Hu J, Yang R, Zhang G, Gu K, Wang L, Wang Q, Wei Z, Li Z, Lu H, Zhang H, Chen H, Song T. Shi Y, et al. Among authors: chen g, chen h. J Thorac Oncol. 2022 Oct;17(10):1205-1215. doi: 10.1016/j.jtho.2022.05.011. Epub 2022 Jun 2. J Thorac Oncol. 2022. PMID: 35659581 Free article.

5

A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility.

Guo J, Yu W, Li M, Chen H, Liu J, Xue X, Lin J, Huang S, Shu W, Huang X, Liu Z, Wang S, Qiao Y. Guo J, et al. Among authors: chen h. Mol Cell. 2023 May 18;83(10):1710-1724.e7. doi: 10.1016/j.molcel.2023.04.012. Mol Cell. 2023. PMID: 37141888 Free article.

6

Depletion of m⁶ A reader protein YTHDC1 induces dilated cardiomyopathy by abnormal splicing of Titin.

Gao S, Sun H, Chen K, Gu X, Chen H, Jiang L, Chen L, Zhang S, Liu Y, Shi D, Liang D, Xu L, Yang J, Ruan Y, Chen H, Shen B, Ma H, Chen YH. Gao S, et al. Among authors: chen k, chen l, chen yh, chen h. J Cell Mol Med. 2021 Dec;25(23):10879-10891. doi: 10.1111/jcmm.16955. Epub 2021 Oct 30. J Cell Mol Med. 2021. PMID: 34716659 Free PMC article.

7

Clinicopathological features and prognosis of patients with esophageal cancer as the second primary cancer: a large population-based analysis using the SEER program [2000-2015].

Chen Z, Li M, Ma K, Hu Z, Wang S, Chen H, Zheng Y, Zhan C, Lin Z, Wang Q. Chen Z, et al. Among authors: chen h. Transl Cancer Res. 2020 Feb;9(2):1113-1124. doi: 10.21037/tcr.2019.12.64. Transl Cancer Res. 2020. PMID: 35117455 Free PMC article.

8

Efficient DNA interrogation of SpCas9 governed by its electrostatic interaction with DNA beyond the PAM and protospacer.

Zhang Q, Chen Z, Wang F, Zhang S, Chen H, Gu X, Wen F, Jin J, Zhang X, Huang X, Shen B, Sun B. Zhang Q, et al. Among authors: chen z, chen h. Nucleic Acids Res. 2021 Dec 2;49(21):12433-12444. doi: 10.1093/nar/gkab1139. Nucleic Acids Res. 2021. PMID: 34850124 Free PMC article.

9

HGH1 and the immune landscape: a novel prognostic marker for immune-desert tumor microenvironment identification and immunotherapy outcome prediction in human cancers.

Wu G, Dong Y, Hu Q, Ma H, Xu Q, Xu K, Chen H, Yang Z, He M. Wu G, et al. Among authors: chen h. Cell Cycle. 2023 Sep;22(18):1969-1985. doi: 10.1080/15384101.2023.2260163. Epub 2023 Nov 23. Cell Cycle. 2023. PMID: 37811868 Free PMC article.

10

Performance of the MeltPro TB assay as initial test for diagnosis of pulmonary tuberculosis with drug-resistance detection.

Liu ZB, Cheng LP, Pan HQ, Wu XC, Lu FH, Cao J, Wang L, Wei W, Chen HY, Sha W, Sun Q. Liu ZB, et al. Mol Med. 2023 Nov 7;29(1):153. doi: 10.1186/s10020-023-00743-1. Mol Med. 2023. PMID: 37936093 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94,745 results

Search Page

Filters